Back to ROYCE & ASSOCIATES LP ROYCE & ASSOCIATES LP

CDNACDNA
Showing 8 of 30 quarters

Position history for ROYCE & ASSOCIATES LPROYCE & ASSOCIATES LP's holdings in CareDx, Inc.

ROYCE & ASSOCIATES LP holds 575,971 shares of CDNA (CareDx, Inc.), worth $16.4M as of 2026-Q2. The position was increased (+4.1% shares). CDNA represents 0.1% of ROYCE & ASSOCIATES LP's portfolio.

Current Value

$16.4M

Current Shares

575,971

Total Value Change

+$4.1M

Total Shares Change

+182,685

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
575,971
+4.1%
$16.4M0.1%$28.50
35
2026-Q1
Decreased
553,197
-4.8%
$9.6M0.1%$18.80
0
2025-Q4
Increased
581,211
+43.7%
$11M0.1%$19.07
45
2025-Q3
Decreased
404,394
-48.1%
$5.9M0.1%$14.86
0
2025-Q2
Increased
778,604
+61.1%
$15.2M0.2%$19.23
49
2025-Q1
Decreased
483,331
-0.2%
$8.6M0.1%$17.96
0
2024-Q4
Increased
484,286
+23.1%
$10.4M0.1%$21.18
34
2024-Q3
Increased
393,286
+0.3%
$12.3M0.1%$29.70
33

Other major holders of CDNA: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FRED ALGER MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used